BioWorld MedTech

July 1, 2013

Multicenter study to evaluate HeartLight for persistent AF

CardioFocus (Marlborough, Massachusetts), a developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), said that its HeartLight technology is the focus of a multicenter European clinical study for the treatment of drug-refractory persistent AF. Read More

High rates of chronic kidney disease lead to opportunities in India

International report: Thermo Fisher establishes China Innovation Center

Washington roundup: Yale; Infuse better than graft; cancer data are 'inconclusive'

Deals roundup: Bard to sell Electrophysiology unit to Boston Sci for $275M

Agreements/contracts: Zecotek collaborates with IV on IP strategy programs

HIT roundup: McKesson Pharmacy releases a mobile delivery application

Product Briefs

Med-Tech Notes

MDD's Neurology Extra

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...